Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
152M
-
Number of holders
-
536
-
Total 13F shares, excl. options
-
150M
-
Shares change
-
+113M
-
Total reported value, excl. options
-
$12.5B
-
Value change
-
+$9.25B
-
Put/Call ratio
-
0.68
-
Number of buys
-
496
-
Number of sells
-
-77
-
Price
-
$82.88
Significant Holders of BIO-TECHNE Corp - COMMON STOCK (TECH) as of Q4 2022
606 filings reported holding TECH - BIO-TECHNE Corp - COMMON STOCK as of Q4 2022.
BIO-TECHNE Corp - COMMON STOCK (TECH) has 536 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 150M shares
of 152M outstanding shares and own 98.73% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (18.2M shares), BlackRock Inc. (15.9M shares), Select Equity Group, L.P. (7.15M shares), STATE STREET CORP (6.35M shares), BAMCO INC /NY/ (5.52M shares), Neuberger Berman Group LLC (4.13M shares), GEODE CAPITAL MANAGEMENT, LLC (3.68M shares), BROWN CAPITAL MANAGEMENT LLC (3.3M shares), WELLINGTON MANAGEMENT GROUP LLP (3.22M shares), and Winslow Capital Management, LLC (3.15M shares).
This table shows the top 536 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.